BAX

Official Full Name

BCL2 associated X, apoptosis regulator

Organism

Homo sapiens

Gene ID

581

Background

The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2, and functions as an apoptotic activator. The association and the ratio of BAX to BCL2 also determines survival or death of a cell following an apoptotic stimulus. This protein is reported to interact with, and increase the opening of, the mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants, which encode different isoforms, have been reported for this gene. [provided by RefSeq, Dec 2019]

Synonyms

BCL2L4

Cat.No.	Product Name	Price
CSC-DC001332	Panoply™ Human BAX Knockdown Stable Cell Line	Inquiry
CSC-RK0257	Human BAX Knockdown Cell Line-HeLa	Inquiry
CSC-SC001332	Panoply™ Human BAX Over-expressing Stable Cell Line	Inquiry
CSC-RT0003	Human BAX Knockout Cell Line-DLD-1	Inquiry
CSC-RT0010	Human BAX Knockout Cell Line-SW48	Inquiry
CSC-RT0034	Human BAX Knockout Cell Line-HCT116	Inquiry
CSC-RT0528	Human BAX Knockout Cell Line-HeLa	Inquiry
CLKO-0033	BAX KO Cell Lysate-HeLa	Inquiry

Cat.No.	Product Name	Price
AD00060Z	Human BAX adenoviral particles	Inquiry
AD01720Z	Human BAX adenoviral particles	Inquiry
LV00204Z	Human BAX lentiviral particles	Inquiry

Cat.No.	Product Name	Price
SHG091639	shRNA set against Human BAX(NM_138761.3)	Inquiry
SHG091706	shRNA set against Human BAX(NM_138763.3)	Inquiry
SHG091729	shRNA set against Human BAX(NM_004324.3)	Inquiry
SHH245014	shRNA set against Mouse BAX (NM_007527.3)	Inquiry
SHH245018	shRNA set against Rat BAX (NM_017059.2)	Inquiry
SHG091585	shRNA set against Mouse Bax(NM_007527.3)	Inquiry
SHH245010	shRNA set against Human BAX (NM_004324.3)	Inquiry

Cat.No.	Product Name	Price
CDCL182813	Human BAX ORF clone(NM_138761.3)	Inquiry
CDCR033260	Human BAX ORF clone (NM_138763.3)	Inquiry
CDCR243806	Mouse Bax ORF Clone(NM_007527.3)	Inquiry
CDCR287727	Human BAX ORF Clone(NM_004324.3)	Inquiry
CDCR316865	Human BAX ORF Clone(NM_138764.4)	Inquiry
CDCR378159	Rat Bax ORF Clone(NM_017059.2)	Inquiry
CDFG008250	Human BAX cDNA Clone(NM_138764.4)	Inquiry
CDFH001661	Human BAX cDNA Clone(NM_004324.3)	Inquiry
MiUTR1H-00814	BAX miRNA 3'UTR clone	Inquiry
MiUTR1H-00815	BAX miRNA 3'UTR clone	Inquiry
MiUTR1H-00816	BAX miRNA 3'UTR clone	Inquiry
MiUTR1M-01980	BAX miRNA 3'UTR clone	Inquiry
MiUTR3H-03100	BAX miRNA 3'UTR clone	Inquiry
SKO0328	BAX Validated sgRNA vector	Inquiry
CDCB180518	Rabbit BAX ORF clone (XM_002723696.2)	Inquiry
CDCS411731	Human BAX ORF Clone (BC014175)	Inquiry

Detailed Information

Apoptosis is the main type of programmed cell death in animals, participating to the modeling of organs during the development, and to tissue homeostasis during the whole life. Is activated after external or internal stimulation and leads to non-inflammatory reactions, opposite to other forms of cell death, such as necrosis. The group of proteins known as Bcl-2 family members are central players of apoptosis, because they form the interface between the early signaling events that cause cells to enter the apoptotic process and the events that later confer apoptosis characteristics to the cells, leading to their elimination by the immune system. Family members of Bcl-2 are characterized by four homologous domains, termed BH1 to BH4. Classically, the Bcl-2 family is divided into three subfamilies: anti-apoptotic proteins (e.g. Bcl-2, Bcl-xL), pro-apoptotic proteins (e.g. Bax, Bak, Bok) and only BH3 proteins (e.g. Bid, Bad).

The homologue function of Bcl-2 is critical for the regulation of mitochondrial outer membrane permeabilization (MOMP), the key event irreversibly engaging the cells towards death. After MOMP, a specific set of proteases is activated. This activation occurs through two processes: (1) procaspase is cleaved into two subunits and recombined into active heterotetramers and (2) IAPs, a family of caspases inhibitors, are inactivated. It is now widely accepted by investigators that MOMP is caused by the formation of large pores on the outer membrane of mitochondria (MOM), which enables the release of several proteins from the mitochondrial intermembrane space to the cytosol. There are five proteins have been identified as ‘apoptogenic factors’. Among the apoptogenic factors, cytochrome c is one of the most ubiquitous and conserved proteins in the whole living world, a feature most certainly related to its central function as a mobile electron carrier that shuttles between respiratory complexes. Therefore, it can be used as a universal mark for MOMP, including in model systems that do not carry out6 canonical apoptosis. Most specifically, the release of cytochrome c became a criterion in the study of the function of Bcl-2 homologs in animals after expression in yeast. The expression of human Bax was shown to promote the release of cytochrome c in yeast even before it was shown in human cells. Like in mammalian cells, several death signals in yeast, such as acetic acid treatment, induces significant mitochondrial morphological changes and non-selective release of membrane clearance proteins, which have homologies with mammalian apoptogenic factors. Interestingly, Bax effects in yeast do not depend on other proteins that are released following death stimuli, such as acetic acid treatment, that may induce a necrotic type of death depending on massive mitochondrial permeabilization resembling mPTP. This supports the view that, in mammalian cells, only cytochrome would be released through Bax-formed channels, while other apoptogenic factors would be released through other systems, such as mPTP or ceramides channels.

Fig. 1. Mitochondrial proteins released during cell death in mammals and yeast. (T.T. Renault et al. Mechanisms of Ageing and Development. 2017).

Bax retrotranslocation

It has long been believed that Bax translocation from the cytoplasm to the mitochondria is a one-way process. This came from the observation that, in non-apoptotic cells, Bax localization is essentially diffuse in the cytosol while, after apoptosis is triggered, it is relocated to mitochondria to form membrane-inserted oligomers that are responsible for MOMP. However, important observations indicate that passage from soluble/monomer Bax to membrane insertion/oligo-Bax expression is not a one-step method. For example, it has been shown that, during anoikis, Bax could be relocalized to mitochondria, but that the process was reversible. T.T. Renault et al. demonstrated that the 'mitochondrial Bax gene' is not a mandatory 'membrane insertion' Bax protein. Structural studies have allowed designing a complex Bax mutant that has a constitutive mitochondrial localization but that cannot support the conformational change associated to the oligomerization, thus remaining incompetent for cytochrome c release. When expressed in HCT-116 or in HeLa cells, the GFP-tagged form of this mutant showed mitochondrial localization and did not trigger apoptosis. After photobleaching of GFP fluorescence in the nucleus, both nuclear and cytoplasmic fluorescence disappeared, while mitochondrial fluorescence remained. This reflected the rapid dynamics of exchange between the nucleus and the cytosol, and its absence for mitochondrial Bax. However, by following the re-appearance of the fluorescence in the cytosol, the authors showed that a fraction of mitochondrial Bax could be retrotranslocated from the mitochondria to the cytosol. Most interestingly, this reverse transposition process is greatly accelerated when the anti-apoptotic protein Bcl-xl is overexpressed. This led the authors to conclude that, in non-apoptotic cells, (1) Bax subcellular localization followed a dynamic equilibrium between mitochondria and cytosol and that (2) anti-apoptotic proteins could displace this equilibrium towards a more cytosolic localization. An additional interesting observation was that a mutant of Bcl-xL deleted of the C-terminal α-helix (Bcl-xLΔC) was unable to promote Bax retrotranslocation, and further experiments demonstrated that the deletion of the last residues of Bcl-xL were sufficient to prevent it.

Fig. 2. Comparison of the effects of full-length Bcl-xL and truncated Bcl-xLΔC on Bax mitochondrial localization. (T.T. Renault et al. Mechanisms of Ageing and Development. 2017).

References:

T.T. Renault et al. A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2. Mechanisms of Ageing and Development. Volume 161, Part B, January 2017, Pages 201-210.
Aouacheria et al. Hardwick.Evolution of Bcl-2 homology motifs: homology versus homoplasy. Trends Cell Biol. 23 (2013), pp. 103-111.
Beaumatin et al. N52 monodeamidated Bcl-xL shows impaired oncogenic properties in vivo and in vitro. Oncotarget, 7 (2016), pp. 17129-17143.
S. Bleicken, G. Jeschke, C. Stegmueller, R. Salvador-Gallego, A.J. García-Sáez, E. Bordignon. Structural model of active Bax at the membrane. Mol. Cell., 56 (2014), pp. 496-505.
L. Große, C.A. Wurm, C. Brüser, D. Neumann, D.C. Jans, S. Jakobs. Bax assembles into large ring-like structures remodeling the mitochondrial outer membrane in apoptosis. EMBO J. 35 (2016), pp. 402-413.

Quick Inquiry

BAX

You might be looking for:

Detailed Information